Navigation Links
Results promising for computational quantum chemical methods for drug development
Date:12/20/2007

Blacksburg, Va. New research, led by a Virginia Tech chemist, may someday help natural-products chemists decrease by years the amount of time it takes for the development of certain types of medicinal drugs. The research by T. Daniel Crawford, associate professor of chemistry, involves computations of optical rotation angles on chiralnon-superimposablemolecules. The research titled, The Current State of Ab Initio Calculations of Optical Rotation and Electronic Circular Dichcoism Spectra, appeared recently as the cover article in The Journal of Physical Chemistry A.

Many chiral molecules are important for medical treatment for illnesses ranging from acid-reflux to cancer. The term chiral means that two mirror images of a molecule cannot be superimposed onto each other. In other words, some are left-handed and some are right-handed.

Most drugs have this handedness property, Crawford said, and for many of these drugs, even though both hands can cause a reaction, it is a situation where one hand does a good thing and one does a bad thing. He used thalidomide as an example. A mixture of both hands of the drug was used in the late 1950s and early 1960s to treat morning sickness in pregnant women. Later studies revealed that, while one of the two hands acted as the desired sedative, the other hand was found to cause significant birth defects. Thalidomide was never approved by the FDA in the United States and was eventually taken off the market in Europe.

For chemists, therefore, it is often vital to determine which hand of a molecule they are using. In other words, when you have a sample of a chiral molecule, how do you distinguish between the left and right hand"

This is where a technique called polarimetry comes in to play. By shooting plane-polarized light through a sample of one hand, the chiral molecule in question will rotate to a characteristic angle either clockwise or counterclockwise, and the two hands of a chiral molec
'/>"/>

Contact: Catherine Doss
cdoss@vt.edu
540-231-5035
Virginia Tech
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Brooke Franchise Corporation Announces Selected July Results
3. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
4. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
5. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
6. NBTY Announces Preliminary Unaudited Net Sales Results For August 2007
7. Martek Announces Third Quarter 2007 Financial Results
8. MDS Reports Third Quarter 2007 Results
9. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
10. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...to be the first malarial outbreak in 40 years, hea...have come down with malaria.// No fresh cases of ...he major resort locations are free of the infectio...s one of the world‘s deadliest diseases, killing a...
...risk factor for cardiovascular diseases.A potbelly...re even if the rest of the body is skinny as a bea...ctor of risk is the relationship of waist size to ...atio predicts an increased risk of heart attack. T...
...ts plea to doctors over prescription of cheaper dr...ions in the coming year if GPs// prescribed cheape...s (PCTs) can prescribe generic versions of the dru...e two of five ‘statin’ drugs that are approved for...
... potential beneficial effects of TNFa inhibition i...anti-TNFa treatment in aging," appears in the Janu...his study shows hope for significantly reducing va...TNFa, which has been linked to blood vessel dysfun...
Other Medicine News:Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2
(Date:7/22/2008)...lidated by Columbia University Medical Center Base...RNA Technology, The Test Differentiates Squamous...CLC), Classifying Squamous-Cell Carcinoma of the L...ificity of 90 Percent,This is the First CLIA Appro... as Biomarkers for Accurate Diagnosis of Lun...
(Date:7/22/2008)... France, July 22 /- NicOx S...uccessfully completed the,enrollment of 417 osteoa...n,in two clinical pharmacology studies in the Unit...ines. These trials are designed to assess the,bloo...o ibuprofen and,naproxen, using the Ambulatory Blo...
(Date:7/22/2008)...sts That Ekkyo,s New Approach of LASH (Laser Assis... Healing Physiology, MARSEILLES, France, July 22 ...Technology) a photomedicine company, which develop... prevention and reduction, announced today,the pub...ery and Medicine*,reporting the results of a pilot...
(Date:7/21/2008)... /- Ari Kiev, M.D., president of SPRI...e upcoming conference Wall,Street Unplugged: The T...to,Wall Street. The conference will be held on Wed...fth Avenue in New York. The event is targeted to C... science companies to gain,better insight into Wal...
Breaking Medicine Technology:First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Health Fitness Completes Share Repurchase Plan 20254 1Health Fitness Completes Share Repurchase Plan 20254 2Current vitamin D recommendations fraction of safe perhaps essential levels for children 20248 1Current vitamin D recommendations fraction of safe perhaps essential levels for children 20248 2ev3 Inc to Present at the Goldman Sachs Twenty Ninth Annual Global Healthcare Conference 20245 1Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI COR Biosciences 5622 1Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI COR Biosciences 5622 2Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI COR Biosciences 5622 3
... Disease Week -, CAMBRIDGE, Mass., May 21, 2007 /P...ation of data from a Phase 2 study in which,linacl...el function,in patients with constipation- predomi...also showed linaclotide was well tolerated with,a ...first-in-class,compound currently being developed ...
...ts from phase III,clinical trials and further huma...Congress of the European Academy of,Dermatology an...fficacy and safety profile of alitretinoin as a po...h severe refractory chronic,hand eczema. , Current...c Hand,Eczema (CHE) refractory or unresponsive to ...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
...ue processor features superior user comfort with s...closed, stand-alone system for processing of up to...ocessor combines proven technology with an innovat... use,yet powerful software. Many routine user oper...
...mily are semi-enclosed tissue processors. The Leic...nology with modern and functionally enhanced desig...or tissues at all stages of the processing run, ro...mechanics in conjunction with a modern user interf...
...w tissue infiltration instrument, which combines w...erly way. The robust caroussel design is proven an... instrument includes either 10 reagent and 2 paraf...ers. Up to 10 different programs can be stored all...
...with automatic fine/trim- feed system, specimen re...ecision cross roller bearings. For sectioning para...in biological, botany, and materials science. Spec...Performance, ergonomy and design of this sliding m...
Medicine Products: